Consolidated Statements of Redeemable Noncontrolling Interest, Redeemable Convertible Preferred Stock, and Stockholders' Equity (Deficit) - USD ($)
Total
Cumulative Effect, Period of Adoption, Adjustment [Member]
Whitehat A I [Member]
Previously reported
Conversion of shares due to Reverse Recapitalization
Convertible debt
Convertible warrants
Redeemable convertible preferred stock
Redeemable convertible preferred stock
Previously reported
Redeemable convertible preferred stock
Conversion of shares due to Reverse Recapitalization
Common Stock
Common Stock
Whitehat A I [Member]
Common Stock
Doc.ai Incorporated [Member]
Common Stock
Previously reported
Common Stock
Conversion of shares due to Reverse Recapitalization
Common Stock
Convertible debt
Common Stock
Convertible warrants
Common Stock
Redeemable convertible preferred stock
Common Stock
Redeemable Noncontrolling Interset [Member]
Additional Paid-In Capital
Additional Paid-In Capital
Whitehat A I [Member]
Additional Paid-In Capital
Previously reported
Additional Paid-In Capital
Conversion of shares due to Reverse Recapitalization
Additional Paid-In Capital
Convertible debt
Additional Paid-In Capital
Convertible warrants
Accumulated Other Comprehensive Loss
Accumulated Other Comprehensive Loss
Previously reported
Accumulated Deficit
Accumulated Deficit
Previously reported
Noncontrolling Interest
Noncontrolling Interest
Previously reported
Redeemable noncontrolling interest, beginning balance at Dec. 31, 2017 [1]       $ 0                                                      
Redeemable Noncontrolling Interest                                                              
Issuance of redeemable noncontrolling interest for and stock for Visualize Health acquisitions                                                            
Redeemable noncontrolling interest, ending balance at Dec. 31, 2018 [1]       $ 0 $ 0                                                    
Redeemable convertible preferred stock, beginning balance (in shares) at Dec. 31, 2017                 810,354                                            
Redeemable convertible preferred stock, beginning balance at Dec. 31, 2017 [1]                 $ 158,653,000                                            
Redeemable convertible preferred stock, beginning balance (in shares) at Dec. 31, 2018 [1]               0   (810,354)                                          
Redeemable convertible preferred stock, ending balance at Dec. 31, 2018 [1]               $ 0   $ (158,653,000)                                          
Beginning balance (in shares) at Dec. 31, 2017 [1]                           2,013,526                                  
Beginning balance at Dec. 31, 2017 [1] (142,827,000)                         $ 2,000               $ 148,675,000         $ (734,000)   $ (293,593,000)   $ 2,823,000
Ending balance at Dec. 31, 2018 [1] 15,828,000 $ 1,478,000     $ 158,655,000           $ 22,000       $ 20,000         $ 307,310,000     $ 158,635,000     $ (734,000)   $ (293,593,000)   $ 2,823,000  
Ending balance (in shares) at Dec. 31, 2018 [1]                     201,225,566       199,212,040                                
Redeemable noncontrolling interest, ending balance at Dec. 31, 2019 [1] 0                                                            
Redeemable Convertible Preferred Stock                                                              
Issuance of Series D stock (in shares) [1]                     51,805                                        
Redeemable convertible preferred stock, beginning balance (in shares) at Dec. 31, 2019 [1]               0                                              
Redeemable convertible preferred stock, ending balance at Dec. 31, 2019 [1]               $ 0                                              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                                              
Stock options exercised (in shares) [1]                     97,482                                        
Stock options exercised [1] 69,000                                     69,000                      
Issuance of warrants [1] 2,639,000                                     2,639,000                      
Conversion of convertible securities (in shares) [1]                     4,866,602                                        
Conversion of convertible securities [1] 1,000                                     1,000                      
Share-based compensation [1] 3,532,000                                     $ 3,532,000                      
Net income (loss) attributable to noncontrolling interest in subsidiaries [1] 543,000                                                            
Currency translation adjustment [1] (583,000)                                                 (468,000)       (115,000)  
Net income (loss) attributable to Sharecare, Inc. $ (39,980,000)                                                            
Issuance of Series C preferred stock, net of issuance costs                     $ 4,809,951,000                                        
Issuance of Series C preferred stock, net of issuance costs (in shares) [1] 25,330                                     25,330                      
Beneficial conversion feature in connection with convertible debt [1] $ 702,000                                     $ 702,000                      
Other [1] $ 543,000                                                         543,000  
Other (in shares) [1] (39,980)                                                     (39,980)      
Ending balance at Dec. 31, 2019 [1] $ 9,559,000                   $ 22,000                 339,583,000           (1,202,000)   $ (332,095,000)   3,251,000  
Ending balance (in shares) at Dec. 31, 2019 [1]                     211,051,406                                        
Redeemable Noncontrolling Interest                                                              
Issuance of redeemable noncontrolling interest for and stock for Visualize Health acquisitions 5,040,000                                                            
Change in fair value of redeemable noncontrolling interest in subsidiaries [1] 960,000                                     (960,000)                      
Expiration of Visualize Health put options [1] (1,026,000)                                                            
Redeemable noncontrolling interest, ending balance at Dec. 31, 2020 $ 4,000,000                                                            
Redeemable convertible preferred stock, ending balance at Dec. 31, 2020 [1]               $ 0                                              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                                              
Stock options exercised (in shares) 352,659                   352,658 [1]                                        
Stock options exercised [1] $ 338,000                                     338,000                      
Issuance of redeemable noncontrolling interest for and stock for Visualize Health acquisitions [1] 584,000                                     584,000                      
Change in fair value of redeemable noncontrolling interest in subsidiaries [1] (960,000)                                                            
Issuance of warrants [1] $ 1,097,000                                     $ 1,097,000                      
Issuance of stock for acquisitions (in shares) [1] 7,548                   3,386,990 1,425,171               7,548                      
Issuance of stock for acquisitions [1]     $ 2,160,000                                   $ 2,160,000                    
Share-based compensation [1] $ 19,160,000                                     $ 19,160,000                      
Net income (loss) attributable to noncontrolling interest in subsidiaries [1] (443,000)                                                         (443,000)  
Currency translation adjustment [1] (241,000)                                                 500,000       (741,000)  
Net income (loss) attributable to Sharecare, Inc. [1] (60,018,000)                                                     (60,018,000)      
Beneficial conversion feature in connection with convertible debt [1]                                       (135,000)                      
Issuance of stock for Wellstar investment (in shares) [1]                     890,732                                        
Issuance of stock for Well star investment [1] 6,745,000                                     6,745,000                      
ASC 810-10 Visualize Health NCI Attribution [1] (7,000)                                     (7,000)                      
Redemption of Visualize Health put options [1] (974,000)                                                            
Expiration of Visualize Health put options [1] 1,026,000                                     890,000                   136,000  
Other [1] 131,000                                     131,000                      
Ending balance at Dec. 31, 2020 [1] $ (13,456,000)                   $ 22,000               $ 4,000,000 377,134,000           (702,000)   (392,113,000)   2,203,000  
Ending balance (in shares) at Dec. 31, 2020 217,106,957             0 [1]     217,106,957 [1]                                        
Redeemable Noncontrolling Interest                                                              
Dissolution of redeemable noncontrolling interest for Visualize Health [1] $ (4,000,000)                                                            
Redeemable noncontrolling interest, ending balance at Dec. 31, 2021 0                                                            
Redeemable Convertible Preferred Stock                                                              
Issuance of stock for Series D antidilution provision (in shares) [1]               546,341                                              
Issuance of stock for Series D antidilution provision [1]               $ 6,451,000                                              
Issuance of Series D stock (in shares) [1]               4,453,659                                              
Issuance of Series D stock [1]               $ 51,754,000                                              
Redeemable convertible preferred stock, ending balance at Dec. 31, 2021 [1] $ 58,205,000                                                            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                                              
Stock options exercised (in shares) 15,788,241                   15,067,237 [1]                                        
Stock options exercised [1] $ 15,434,000                   $ 2,000                 15,432,000                      
Issuance of redeemable noncontrolling interest for and stock for Visualize Health acquisitions [1] 81,293,000                   8,435,301,000                 81,292,000                      
Issuance of warrants [1] 79,000                                     79,000                      
Issuance of stock for doc.ai antidilution provision [1] 12,682,000                   $ 1,052,398,000                 12,682,000                      
Conversion of convertible securities (in shares) [1]           37,695,910 11,647,316                                                
Conversion of convertible securities [1]           $ 136,399,000 $ 11,481,000                 $ 4,000 $ 1,000             $ 136,395,000 $ 11,480,000            
Issuance of stock for acquisitions (in shares) [1]                     1,262,475                                        
Issuance of stock for acquisitions [1] 10,348,000                       $ 1,000             10,348,000                      
Business Combination and Private Placement financing, net of issuance costs (in shares) [1]                     57,451,915                                        
Business Combination and Private Placement financing, net of issuance costs [1] 376,576,000                   $ 6,000                 376,570,000                      
Share-based compensation [1] 46,780,000                                     46,780,000                      
Dissolution of redeemable NCI for Visualize Health (in shares) [1]                     895,435                                        
Dissolution of redeemable noncontrolling interest for Visualize Health [1] 4,000,000                                     4,136,000                   (136,000)  
Cumulative effect of adopting ASU 2021-08 [1] 593,000                                                     593,000      
Net income (loss) attributable to noncontrolling interest in subsidiaries [1] (129,000)                                                 (18,000)       (111,000)  
Currency translation adjustment [1] (1,486,000)                                                 (1,341,000)       (145,000)  
Net income (loss) attributable to Sharecare, Inc. (85,000,000)                                                     (85,593,000) [1]      
Common stock issued to settle contingent consideration from acquisitions in prior years (in shares) [1]                     1,078,213                                        
Settlement of contingent liability on Whitehat earnout [1] $ 595,000                                     595,000                      
Common stock issued upon vesting of restricted stock units (in shares) [1]                     31,250                                        
Repurchased shares of common stock related to exercise of employee stock options (in shares) 19,864,030                   (6,002,255) [1]                                        
Repurchased shares of common stock related to exercise of employee stock options [1] $ (29,772,000)                   $ (1,000)                 (29,771,000)                      
Other [1] (988,000)                                     (988,000)                      
Other (in shares) [1]                     66,555                                        
Ending balance at Dec. 31, 2021 [1] $ 564,836,000                   $ 35,000             $ 58,205,000   $ 1,042,164,000           $ (2,061,000)   $ (477,113,000)   $ 1,811,000  
Ending balance (in shares) at Dec. 31, 2021 345,788,707             5,000,000 [1]     345,788,707 [1]                                        
[1] Retroactively restated for the Reverse Recapitalization as a result of the Business Combination as described in Notes 1 and 2.